CleverSkin Technologies Limited remains in development and regulatory preparation and is not currently offered as an approved product for sale in the UK or EU.
Published
Signal category
Products & Services
Quote
“CleverSkin remains in development and regulatory preparation and is not currently offered as an approved product for sale in the UK or EU.”
— CleverSkin Technologies Limited team
Company
CleverSkin Technologies Limited
Advanced wound dressing innovation from London. Open to strategic partners and investors (Seed/Series A)
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 5 employees
CleverSkin Technologies Limited (London, UK) is developing CleverSkin — an advanced wound dressing innovation intended to support wound care across clinical environments. Our focus is building a commercially scalable platform that prioritises quality, safety and partner-led adoption. We are actively seeking investor and strategic partner conversations (Seed / Series A): • Angels, VCs, family offices, investment banks • Owners of medical businesses and healthcare groups • Distributors and national/regional market-entry partners • Manufacturing partners for local production and scale-up Request the investor deck / book an intro: [vt@cleverskintechnologies.co.uk Website: https://cleverskintechnologies.co.uk